301096 百诚医药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(179,786)(195,857)90,453259,413145,424
投资活动产生之现金流量净额(188,483)(464,537)(767,416)(690,871)(251,158)
筹资活动产生之现金流量净额308,907298,090244,482(366,476)1,982,131
汇率变动对现金及现金等价物的影响31313(134)----
现金及现金等价物净增加/(减少)(59,049)(362,291)(432,615)(797,934)1,876,397
期初现金及现金等价物余额416,161778,4531,211,0682,009,002132,605
期末现金及现金等价物余额357,113416,161778,4531,211,0682,009,002